The present invention relates to a novel succinic acid salt of rosiglitazone compound of formula-1, its crystalline form and process for its preparation as well as an improved process for the preparation of rosiglitazone compound of formula-2.
Charges
80 Crore
18 August 2014
Axis Bank Limited
40 Crore
02 September 2008
Indian Overseas Bank
4 Crore
25 August 2021
Hdfc Bank Limited
40 Crore
20 May 2023
Axis Bank Limited
0
25 August 2021
Hdfc Bank Limited
0
18 August 2014
Axis Bank Limited
0
02 September 2008
Indian Overseas Bank
0
20 May 2023
Axis Bank Limited
0
25 August 2021
Hdfc Bank Limited
0
18 August 2014
Axis Bank Limited
0
02 September 2008
Indian Overseas Bank
0
Documents
Form DPT-3-03042021_signed
Form DPT-3-04062020-signed
Form MGT-7-27122019_signed
Copy of MGT-8-26122019
List of share holders, debenture holders;-26122019
Form AOC-4(XBRL)-08122019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-01122019
Form ADT-1-13112019_signed
Copy of written consent given by auditor-13112019
Copy of the intimation sent by company-13112019
Copy of resolution passed by the company-13112019
Form DPT-3-30062019
Form ADT-1-11062019_signed
Optional Attachment-(1)-11062019
Copy of written consent given by auditor-11062019
Optional Attachment-(2)-04042019
Form CHG-1-04042019_signed
Optional Attachment-(1)-04042019
Instrument(s) of creation or modification of charge;-04042019
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20190404
Form AOC-4-26122018_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-24122018
Directors report as per section 134(3)-24122018
Company CSR policy as per section 135(4)-24122018
List of share holders, debenture holders;-05122018
Copy of MGT-8-05122018
Form MGT-7-05122018_signed
Form CHG-1-22012018_signed
Optional Attachment-(1)-22012018
Instrument(s) of creation or modification of charge;-22012018